BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,822,700 | +293.1% | 80,839 | +127.6% | 0.01% | +300.0% |
Q2 2023 | $2,244,358 | -26.9% | 35,512 | -48.0% | 0.00% | -25.0% |
Q1 2023 | $3,071,377 | +4.8% | 68,268 | +2.1% | 0.00% | -20.0% |
Q4 2022 | $2,930,670 | -99.9% | 66,895 | -1.5% | 0.01% | -28.6% |
Q3 2022 | $4,475,842,000 | +198.7% | 67,929 | +129.0% | 0.01% | +250.0% |
Q2 2022 | $1,498,531,000 | +177.0% | 29,668 | +250.4% | 0.00% | +100.0% |
Q1 2022 | $540,936,000 | -59.1% | 8,468 | -31.5% | 0.00% | -50.0% |
Q4 2021 | $1,323,987,000 | +22.5% | 12,361 | +17.6% | 0.00% | 0.0% |
Q3 2021 | $1,081,047,000 | +99.2% | 10,515 | +70.4% | 0.00% | +100.0% |
Q2 2021 | $542,713,000 | -71.4% | 6,170 | -19.1% | 0.00% | -66.7% |
Q1 2021 | $1,896,568,000 | -26.4% | 7,626 | -66.8% | 0.00% | -40.0% |
Q4 2020 | $2,575,861,000 | +115.4% | 22,968 | +78.1% | 0.01% | +150.0% |
Q3 2020 | $1,195,645,000 | -65.7% | 12,898 | -71.2% | 0.00% | -66.7% |
Q2 2020 | $3,490,188,000 | -8.5% | 44,746 | -31.4% | 0.01% | -25.0% |
Q1 2020 | $3,813,715,000 | -44.5% | 65,214 | -23.9% | 0.01% | -38.5% |
Q4 2019 | $6,868,391,000 | +940.6% | 85,737 | +854.3% | 0.01% | +1200.0% |
Q3 2019 | $660,054,000 | +13.7% | 8,984 | +45.9% | 0.00% | 0.0% |
Q2 2019 | $580,695,000 | -24.3% | 6,156 | -35.8% | 0.00% | -50.0% |
Q1 2019 | $767,519,000 | +727.7% | 9,588 | +457.4% | 0.00% | – |
Q4 2018 | $92,725,000 | -72.0% | 1,720 | -59.4% | 0.00% | – |
Q3 2018 | $330,974,000 | +29.2% | 4,240 | +5.0% | 0.00% | – |
Q2 2018 | $256,269,000 | -68.5% | 4,037 | -54.5% | 0.00% | -100.0% |
Q1 2018 | $813,562,000 | +23.1% | 8,872 | +1.3% | 0.00% | +100.0% |
Q4 2017 | $660,667,000 | +129.5% | 8,761 | +112.0% | 0.00% | 0.0% |
Q3 2017 | $287,876,000 | +34.1% | 4,132 | -2.5% | 0.00% | 0.0% |
Q2 2017 | $214,739,000 | +5674.1% | 4,238 | +4457.0% | 0.00% | – |
Q1 2017 | $3,719,000 | -88.3% | 93 | -91.8% | 0.00% | – |
Q4 2016 | $31,893,000 | -23.9% | 1,137 | -19.5% | 0.00% | – |
Q3 2016 | $41,936,000 | +164.1% | 1,412 | +80.1% | 0.00% | – |
Q2 2016 | $15,876,000 | -68.5% | 784 | -59.1% | 0.00% | – |
Q4 2015 | $50,468,000 | -2.8% | 1,916 | -21.3% | 0.00% | – |
Q3 2015 | $51,942,000 | – | 2,434 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |